Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daiichi Sankyo
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of type 2 diabetes
Male or female at least 18 years of age
Hemoglobin A1C \> 7% and less or equal to 8.5%
Non-fasting C-peptide \> 0.5 ng/mL
Current monotherapy treatment with stable dose of approved non-Thiazolidinedione (TZD) antihyperglycemic medication for greater or equal to 3 months prior to screening or
Untreated with any antihyperglycemic agent during 2 months prior to screening
You may not be if
History of type 1 diabetes or ketoacidosis
History of long-term therapy with insulin
Body Mass Index (BMI) \> 45 kg/m\^2
Known history of Congestive Heart Failure (CHF)
Impaired hepatic function
History of prior treatment failure with, or intolerance of, a TZD
Contraindication to treatment with pioglitazone
Treatment with fibrates
If untreated with oral antihyperglycemic, considered to have failed diet and exercise modification as the sole treatment for type 2 diabetes